Status:
COMPLETED
A Randomized Patient Preference Trial on Heat-sensitive Moxibustion for Primary Hypertension in Community
Lead Sponsor:
Jiangxi University of Traditional Chinese Medicine
Conditions:
Primary Hypertension
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Heat-sensitive moxibustion, an important mean of external therapy of traditional Chinese medicine, has unique advantages in treating various chronic diseases than common moxibustion. This study aims t...
Detailed Description
Primary hypertension is a common chronic disease that threatens the life and health of human beings. The conventional western drug therapy often has side effects and many patients are unable to achiev...
Eligibility Criteria
Inclusion
- Diagnosed with essential hypertension, i.e., systolic blood pressure ≥ 140mmHg and/or diastolic blood pressure ≥ 90 mmHg, with a course more than 6 months.
- Ages: 18-80 years;
- The original antihypertensive drugs are calcium channel blockers and/or angiotensin II receptor blockers.
- Did not receive acupoint stimulation therapies for hypertension in the last month.
- Patients in the heat-sensitive moxibustion groups need to develop at least one type of moxibustion sensation around the following acupoints: Yongquan, Baihui, Shenque, Quchi, Zusanli, Hegu, Taichong and Dazhui.
- Consent to sign an informed consent form
Exclusion
- Systolic blood pressure ≥ 180mmHg and/or diastolic blood pressure ≥ 110mmHg after taking antihypertensive drugs;
- Secondary hypertension.
- Pregnancy and lactation;
- Allergic to moxibustion devices, moxa smoke or Artemisia argyi.
- Complicated with severe diseases that are not recommended for heat-sensitive moxibustion, such as acute cerebral hemorrhage, hypertensive crisis, sensory disturbances, serious mental diseases, etc.
Key Trial Info
Start Date :
March 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 9 2021
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04788563
Start Date
March 10 2021
End Date
December 9 2021
Last Update
July 3 2024
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Erliuling
Nanchang, Jiangxi, China, 330004
2
Hongmiao
Nanchang, Jiangxi, China, 330004
3
Jinghexinggong community
Nanchang, Jiangxi, China, 330004
4
Jinsheng community
Nanchang, Jiangxi, China, 330004